NeuroSentry has been selected for the Fall 2026 cohort of Caduceus LAUNCH, a digital health accelerator affiliated with Caduceus Capital Partners.
NeuroSentry was one of just five companies selected from more than 175 applicants. The cohort brings together early-stage companies addressing some of healthcare's persistent challenges.
Through LAUNCH, NeuroSentry will receive initial funding and hands-on growth support, tailored mentorship from experienced healthcare leaders, access to investors and the Caduceus network, and support across go-to-market strategy, recruiting, and company building.
The program marks another important step as we work to bring real-time stroke detection to patients who are sedated, under anesthesia, or otherwise unable to undergo a conventional neurological examination.
Check out our Linkedin Post: https://lnkd.in/p/eZ2ckH8x
